Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Danaher Corp (NY: DHR )

228.55 +2.39 (+1.06%)
Official Closing Price Updated: 7:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,073,627
Open 226.96
Bid (Size) 228.00 (3)
Ask (Size) 230.80 (1)
Prev. Close 226.16
Today's Range 225.42 - 230.81
52wk Range 222.53 - 281.70
Shares Outstanding 722,200,000
Dividend Yield 0.47%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
5 High-Flying Stocks In Dan Loeb's Portfolio: Cinemark, Corpay, Amazon Lead
Dan S. Loeb, founder of Third Point, a $7B hedge fund, is known for bold activist strategies that drive transformation in global companies. 
Via Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
The Benzinga Stock Whisper Index highlights five stocks seeing increased interest from readers during the week and the reasons why the stocks may be drawing attention. 
Via Benzinga

Performance

YTD
-2.66%
-2.66%
1 Month
-3.09%
-3.09%
3 Month
-16.33%
-16.33%
6 Month
-10.99%
-10.99%
1 Year
-1.23%
-1.23%

More News

Read More
Despite Higher Valuations, Some Life Sciences Tools Stocks Create Good Opportunities: Analyst
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
What the Options Market Tells Us About Danaher
Via Benzinga
What the Options Market Tells Us About Danaher
Via Benzinga
Peering Into Danaher's Recent Short Interest
Via Benzinga
Inquiry Into Danaher's Competitor Dynamics In Life Sciences Tools & Services Industry
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
A Look Into Danaher Inc's Price Over Earnings
Via Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $4,600 Today
Via Benzinga
Want to Grow a Passive Income Snowball? Buy These 7 Elite Dividend Growth Stocks.
Via The Motley Fool
Critical Insights From Danaher Analyst Ratings: What You Need To Know
Via Benzinga
Danaher's Q3 Earnings Boosted By Bioprocessing Order Growth, Analyst Maintain Stock Rating
Via Benzinga
A Closer Look at Danaher's Options Market Dynamics
Via Benzinga
Earnings Preview: Danaher
Via Benzinga
This Is What Whales Are Betting On Danaher
Via Benzinga
Stocks Fall, GM Eyes Best Day In A Year, Gold Breaks Records, Silver Hits 12-Year Highs: What's Driving Markets Tuesday?
Via Benzinga
Life Science Giant Danaher Q3 Earnings: Revenue And EPS Beat, Sticks To Annual Guidance
Via Benzinga
Hedge Fund Billionaire Daniel Loeb Bets On Trump Win, Singles Out This Recent Buy As Having 'Significant Upside Potential'
Via Benzinga
Topics Economy Government
Exposures Economy Political
Here's How Much You Would Have Made Owning Danaher Stock In The Last 10 Years
Via Benzinga
Looking Into Danaher's Recent Short Interest
Via Benzinga
Uncovering Noteworthy Technical Analysis Findings for DANAHER CORP (NYSE:DHR).
Via Chartmill
Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers.
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Danaher Is Poised For 'A Good Year In Bioprocessing': Analyst
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.